1. Home
  2. UPC vs NXTS Comparison

UPC vs NXTS Comparison

Compare UPC & NXTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Universe Pharmaceuticals Inc.

UPC

Universe Pharmaceuticals Inc.

HOLD

Current Price

$4.03

Market Cap

3.3M

Sector

Health Care

ML Signal

HOLD

Logo Nexentis Technologies Inc. Common Stock

NXTS

Nexentis Technologies Inc. Common Stock

N/A

Current Price

$1.72

Market Cap

2.8M

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
UPC
NXTS
Founded
1998
2009
Country
China
Israel
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Agricultural Chemicals
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
3.3M
2.8M
IPO Year
2020
2021

Fundamental Metrics

Financial Performance
Metric
UPC
NXTS
Price
$4.03
$1.72
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
95.3K
18.1K
Earning Date
01-29-2026
05-16-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$263,445.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.00
$0.55
52 Week High
$17.96
$23.80

Technical Indicators

Market Signals
Indicator
UPC
NXTS
Relative Strength Index (RSI) 44.84 36.22
Support Level $2.57 $1.43
Resistance Level $4.71 $2.09
Average True Range (ATR) 0.58 0.15
MACD -0.15 0.04
Stochastic Oscillator 27.84 9.09

Price Performance

Historical Comparison
UPC
NXTS

About UPC Universe Pharmaceuticals Inc.

Universe Pharmaceuticals Inc is a pharmaceutical company specializing in the manufacturing, marketing, sales and distribution of traditional Chinese medicine derivatives products targeting the elderly with the goal of addressing their physical conditions in the ageing process and promoting their general well-being. The company also sells biomedical drugs, medical instruments, Traditional Chinese Medicine Pieces, and dietary supplements manufactured by third-party pharmaceutical companies. Its products are under two categories namely treatment and relief for common chronic health conditions in the elderly designed to achieve physical wellness and longevity (Chronic Condition Treatments), and cold and flu medications.

About NXTS Nexentis Technologies Inc. Common Stock

Nexentis Technologies Inc, is engaged in redefining mitochondrial drug discovery with help of its wholly owned biotechnology subsidiary, MitoCareX Bio focused on drug discovery company dedicated to developing first-in-class therapeutics for inflammatory metabolic diseases and cancer by targeting specific metabolic pathways. The company is also focused on sustainable operations in various industries such as solar projects, and oncology biotechnology.

Share on Social Networks: